Enterolactone produced by the metabolism of plant lignans by intestinal bacteria showed anti-proliferative effects in prostate cancer cell lines by repression of DNA licensing genes including MCM7 as well as the miR-106b-25 cluster, and overexpression of tumor suppressor gene PTEN [102] (Table 5). This evidence concerns the gene PTEN and prostate carcinoma.